1. Research updates on the clinical implication of long noncoding RNA in digestive system cancers and chemoresistance
- Author
-
Fang Wang, Muhammad Yunus, Miao Xinzhi, Tianyun Wang, Ida Shazrina Ismail, and Siti Razila Abdul Razak
- Subjects
Oncogene ,Tumor suppressor gene ,RNA ,Review Article ,Environmental Science (miscellaneous) ,Biology ,medicine.disease ,Agricultural and Biological Sciences (miscellaneous) ,Long non-coding RNA ,Pancreatic cancer ,microRNA ,medicine ,Cancer research ,Stem cell ,Gene ,Biotechnology - Abstract
Long noncoding RNAs (lncRNAs) are implicated in various biological processes, such as cell proliferation, differentiation, apoptosis, migration, and invasion. They are also key players in various biological pathways. LncRNA was considered as 'translational noise' before 1980s. It has been reported that lncRNAs are aberrantly expressed in different cancers, either as oncogene or tumor suppressor gene. Therefore, more and more lncRNAs are recognized as potential diagnostic biomarkers and/or therapeutic targets. As competitive endogenous RNA, lncRNAs can interact with microRNA to alter the expression of target genes, which may have extensive clinical implications in cancers, including diagnosis, treatment, prognosis, and chemoresistance. This review comprehensively summarizes the functions and clinical relevance of lncRNAs in digestive system cancers, especially as a potential tool to overcome chemoresistance.
- Published
- 2021